Event Details

Morning of article

Description

Publication of physician survey by Geoffrey Porges.

Participants (2)

Name Type Mentions
Physicians person 0 View Entity
Geoffrey Porges person 6 View Entity

Source Documents (1)

HOUSE_OVERSIGHT_025890.jpg

News Article / Press Release Compilation • 3.12 MB
View

This document appears to be a printout of a news article or press release compilation regarding the FDA approval and market analysis of the Regeneron/Sanofi cholesterol drug, Praluent. It details financial projections, physician surveys, and quotes from executives at Regeneron, Sanofi, and CVS Caremark regarding pricing and accessibility. While the document bears a House Oversight stamp and mentions Donald Trump in a disconnected headline, the content focuses entirely on the pharmaceutical industry.

Event Metadata

Type
Unknown
Location
Unknown
Significance Score
5/10
Participants
2
Source Documents
1
Extracted
2025-11-20 19:18

Additional Data

Source
HOUSE_OVERSIGHT_025890.jpg
Date String
Morning of article

Discussion 0

Sign in to join the discussion

No comments yet

Be the first to share your thoughts on this epstein event